Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.36
-0.09 (-1.40%)
At close: Nov 20, 2024, 4:00 PM
6.33
-0.03 (-0.47%)
After-hours: Nov 20, 2024, 7:54 PM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $354.32 million as of November 21, 2024. Its market cap has decreased by -88.89% in one year.
Market Cap
354.32M
Enterprise Value
183.69M
1-Year Change
-88.89%
Ranking
Category
Stock Price
$6.36
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $354.32M, a decrease of -83.76%. That is a compound annual growth rate of -39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 359.33M | -89.22% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 362.46M |
| Amylyx Pharmaceuticals | 360.84M |
| Enhabit | 359.03M |
| MaxCyte | 356.11M |
| XOMA Royalty | 353.60M |
| Omeros | 343.06M |
| Semler Scientific | 343.04M |
| Kamada | 342.87M |